NMN 150mg Capsule
Natural health product licensed in Canada
- Licence holder
- NuEra Nutraceutical Inc.
- NPN or DIN-HM
- 80137574
- Status
- Active licence
- Licence date
- 6 January 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose, Mannitol, Stéarate de magnésium, Dioxyde de silicium, Amidon de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Nicotinamide mononucleotide is a NAD+ precursor that helps maintain NAD+ levels in the blood for the maintenance of good health. Helps in energy metabolism and tissue formation. Helps to maintain the body's ability to metabolize nutrients. NMN is a source of Vitamin B3, which helps maintains levels of NAD+ in the blood, for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137574
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.